previous compound ID: 1474 next compound
InChIKey: NHUHCSRWZMLRLA-UHFFFAOYSA-N
SMILES: CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "E Matthes" "J Goepp" "JW Hanrahan" "SD Macknight" "R Robert" "DY Thomas" "B Kus" "J Liao" "GW Carlile"

chemical graph of compound 1474





CID is 5344
synonyms found at PubChem are:
sulfisoxazole, Sulfafurazole, 127-69-5, Sulphafurazole, Sulfisoxazol, Sulfafurazol, Sulfaisoxazole, Sulfofurazole, Sulfisoxasole, Sulphaisoxazole, Sulfadimethylisoxazole, Gantrisin, Alphazole, Amidoxal, Sulfalar, Sulfoxol, Sulfisoxazole dialamine, Sulphafurazolum, Renosulfan, Sulfasoxazole, Sulfisonazole, Accuzole, Soxomide, Sulfazin, Sulfizin, Sulsoxin, Sosol, Roxosul tablets, Sulphafurazol, Sulphisoxazol, Sulphofurazole, Chemouag, Cosoxazole, Gantrisona, Gantrosan, Isoxamin, Neazolin, Neoxazol, Sulfagan, Sulfasol, Uritrisin, Entusil, Entusul, Pancid, Soxisol, Stansin, Sulbio, Thiasin, Unisulf, Norilgan-S, Tl-azole, V-Sul, SK-Soxazole, Sulfafurazolum, Sulphadimethylisoxazole, Dorsulfan, Gantrisine, Novazolo, Novosaxazole, Saxosozine, Sodizole, Soxamide, Soxazole, Soxitabs, Sulfapolar, Sulfisin, Sulfizol, Sulfizole, Urisoxin, Roxosul, Urogan, Vagilia, Azo Gantrisin, Dorsulfan warthausen, Koro-sulf, SOXO, Sulfisoxazolum, Sulphisoxazole, 4-amino-N-(3,4-dimethylisoxazol-5-yl)benzenesulfonamide, J-Sul, 3,4-Dimethyl-5-sulfonamidoisoxazole, 3,4-Dimethyl-5-sulfanilamidoisoxazole, 5-Sulfanilamido-3,4-dimethylisoxazole, Benzenesulfonamide, 4-amino-N-(3,4-dimethyl-5-isoxazolyl)-, G-sox, 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide, Sulfazin (VAN), Azosulfizin, Solfafurazolo, Sulfasoxizole, Sulphafuraz, 3,4-Dimethyl-5-sulphonamidoisoxazole, Astrazolo, Bactesulf, Barazae, Neoxazoi, Resoxol, Roxoxol, Sulfagen, Suloxsol, 3,4-Dimethylisoxazole-5-sulfanilamide, Ganda, 3,4-Dimethyl-5-sulphanilamidoisoxazole, 3,4-Dimethylisoxazole-5-sulphanilamide, Solfafurazolo [DCIT], 5-Sulphanilamido-3,4-dimethyl-isoxazole, NCI-C50022, Sulfafurazolum [INN-Latin], ERYZOLE, SULFISOXAZOLE DIOLAMINE, 5-(4-Aminophenylsulfonamido)-3,4-dimethylisoxazole, 5-(p-Aminobenzenesulfonamido)-3,4-dimethylisoxazole, NU 445, Sulfisoxazole [USAN], 5-(p-Aminobenzenesulphonamido)-3,4-dimethylisoxazole, Pediazole, N1-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide, N'-(3,4)Dimethylisoxazol-5-yl-sulphanilamide, Sulfafuraz ole, U.S.-67, Gantrisin (TN), 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulphonamide, CCRIS 568, 5-Sulfanilamido-3,4-dimethyl-isoxazole, HSDB 797, Sulfafurazole (INN), N(Sup1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide, UNII-740T4C525W, C11H13N3O3S, CHEBI:102484, component of Azo-Sulfizin, EINECS 204-858-9, NSC 13120, component of Azo Gantrisin, CHEMBL453, NSC 683536, BRN 0263871, N(sup 1)-(3,4-Dimethyl-5-isoxazolyl)sulphanilamide, AI3-24003, NHUHCSRWZMLRLA-UHFFFAOYSA-N, US-67, Component of Azo Gantrisin Accuzole, NSC13120, 3,4-Dimethylisoxale-5-sulfanilamide, N(sup 1)-(3,4-Dimethyl-5-isoxazolyl)sulfanilamide, NSC683536, Sulfafurazole [INN], 740T4C525W, 3,4-dimethylisoaxazole-5-sulfanilimide, NCGC00016384-03, NCGC00016384-10, 4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide, 4-Amino-N-(3,4-dimethyl-isoxazol-5-yl)-benzenesulfonamide, CAS-127-69-5, DSSTox_CID_1292, N(1)-(3,4-dimethyl-5-isoxazolyl)sulfanilamide, DSSTox_RID_76064, DSSTox_GSID_21292, N(1)-(3,4-dimethyl-5-isoxazolyl)sulphanilamide, Sulfanilamide, N1-(3,4-dimethyl-5-isoxazolyl)-, 5-(p-Aminobenzenesulfonamido)-3,4-dimethylisooxale, Sulfanilamide, N(sup 1)-(3,4-dimethyl-5-isoxazolyl)-, [(4-aminophenyl)sulfonyl](3,4-dimethylisoxazol-5-yl)amine, WLN: T5NOJ CMSWR DZ& D1 E1, Sulfanilamide,4-dimethyl-5-isoxazolyl)-, SMR000037657, Sulfafurazole(SIZ), Benzenesulfonamide,4-dimethyl-5-isoxazolyl)-, SR-01000003085, Sulfisoxazole [USP:JAN], Gantrizin, Sulfisoxazole-Carc, Prestwick_726, Sulfisoxazole - Carc, Spectrum_001024, Tocris-0731, Prestwick0_000334, Prestwick1_000334, Prestwick2_000334, Prestwick3_000334, Spectrum2_001325, Spectrum3_001728, Spectrum4_000349, Spectrum5_001222, Azo-Sulfizin (Salt/Mix), Azo Gantrisin (Salt/Mix), D09TBD, Epitope ID:122240, Sulfisoxazole (JP15/USP), Sulfisoxazole (JP17/USP), Sulfisoxazole, >=99.0%, Oprea1_680668, Oprea1_828173, SCHEMBL23467, BSPBio_000367, BSPBio_003376, KBioGR_000757, KBioSS_001504, 4-27-00-04747 (Beilstein Handbook Reference), MLS000028495, MLS000037737, MLS000563718, BIDD:GT0322, DivK1c_000579, SPECTRUM1500555, SPBio_001449, SPBio_002288, AC1L1K55, BPBio1_000405, DTXSID6021292, CTK7D7932, HMS501M21, KBio1_000579, KBio2_001504, KBio2_004072, KBio2_006640, KBio3_002596, Sulfafurazole;Gantrisin Pediatric, MolPort-000-422-016, NINDS_000579, HMS1569C09, HMS2092K13, HMS2096C09, HMS2233G23, HMS3259C06, HMS3266N17, HMS3374K11, HMS3655B03, HMS3713C09, Pharmakon1600-01500555, ALBB-014131, HY-B0323, NSC33807, NSC38588, ZX-AH011786, Tox21_110409, Tox21_112958, Tox21_202265, Tox21_302851, 6155-81-3 (mono-lithium salt), BDBM50034452, CCG-39263, LS-713, MFCD00003150, NSC-13120, NSC-33807, NSC-38588, NSC757343, s1916, SBB007602, STK400452, ZINC96006009, AKOS000119074, AKOS000310021, Tox21_110409_1, AC-1941, CS-2364, DB00263, MCULE-3522661051, NC00536, NSC-683536, NSC-757343, ABA-9370315, IDI1_000579, 2200-44-4 (mono-hydrochloride salt), NCGC00016384-01, NCGC00016384-02, NCGC00016384-04, NCGC00016384-05, NCGC00016384-06, NCGC00016384-07, NCGC00016384-08, NCGC00016384-09, NCGC00016384-11, NCGC00016384-12, NCGC00016384-14, NCGC00016384-15, NCGC00023116-02, NCGC00023116-05, NCGC00023116-06, NCGC00023116-07, NCGC00023116-08, NCGC00256605-01, NCGC00259814-01, AN-14478, BAS 00531889, BC214921, CPD000037657, R536, SAM002554929, SC-15955, ST059445, SBI-0051529.P003, AB2000373, UPCMLD00X127-69-5:001, AB00052104, BB 0259593, FT-0631743, U0098, C07318, D00450, J10241, Y-9398, AB00052104-14, AB00052104_15, AB00052104_16, Sulfisoxazole, VETRANAL(TM), analytical standard, 5-(4-Aminophenylsulphonamido)-3,4-dimethylisoxazole, J-005528, SR-01000003085-2, SR-01000003085-5, SR-01000003085-6, 5-(4-aminop henylsulfonamido)-3,4-dimethylisoxazole, 5-(p-Aminobenzenesulphonamide)-3,4-dimethylisoxazole, BRD-K50859149-001-05-4, BRD-K50859149-001-10-4, I01-15830, N(sup 1)-(3,4-dimethyl-5-isoxazolyl)-sulfanilamide, Sulfanilamide, N(sup1)-(3,4-dimethyl-5-isoxazolyl)-, Sulfanilamide, N.sup1.-(3,4-dimethyl-5-isoxazolyl)-, F0848-0391, 4-amino-N-(3,4-dimethyl-5-isoxazolyl)benzene-sulfonamide, 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide #, 4-amino-N-(3,4-dimethylisoxazol-5-yl)-benzenesulfonamide, 4-amino-N-(dimethyl-1,2-oxazol-5-yl)benzene-1-sulfonamide, Sulfafurazole, European Pharmacopoeia (EP) Reference Standard, Sulfisoxazole, United States Pharmacopeia (USP) Reference Standard, 1021066-10-3, 207522-06-3, InChI=1/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H